Development

Latest News

medicare price negotiations and biosimilar development  | Image credit: japhoto - stock.adobe.com
Medicare Price Negotiations Will Slow Biosimilar Momentum, Widening Market Gap

July 16th 2025

Government price negotiations under the Inflation Reduction Act may hinder biosimilar development, impacting drug costs and patient access to affordable therapies.

biosimilar development for biologics coming off patent is limited | Image credit: FUTURESEND - stock.adobe.com
White Paper Offers Tips for Sustaining Biosimilar Progress, Avoiding a Market Void

July 15th 2025

vials | Image credit: pixardi - stock.adobe.com
BioRationality: The Urgency of Removing Clinical Efficacy Studies

June 2nd 2025

More News

© 2025 MJH Life Sciences

All rights reserved.